| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David F. Novack | President COO | 2026-01-15 | 20,000 | $6.81 | $136.10kBuy |
| David F. Novack | President COO | 2026-01-15 | 94,000 | $10.47 | $984.18kBuy |
| David F. Novack | President COO | 2026-01-15 | 114,000 | $15.64 | $1.78MSell |
| David F. Novack | President COO | 2025-12-24 | 10,000 | $10.47 | $104.70kBuy |
| Ryan Spencer | CEO and Director | 2025-12-24 | 138,168 | $15.38 | $2.13MSell |
| John L. Slebir | SVP General Counsel | 2025-12-24 | 32,502 | $15.38 | $499.88kSell |
| Joseph Anthony Metzinger | VP Chief Accounting Officer | 2025-12-24 | 5,598 | $15.38 | $86.10kSell |
| David F. Novack | President COO | 2025-12-24 | 30,000 | $15.49 | $464.70kSell |
| David F. Novack | President COO | 2025-12-24 | 20,000 | $6.81 | $136.10kBuy |
| David F. Novack | President COO | 2025-12-24 | 48,107 | $15.38 | $739.89kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Partners L P | 21.48% | 25,226,061 | $390.50M | Insider |
| Blackrock Inc | 13.84% | 16,249,235 | $251.54M | Institution |
| Deep Track Biotechnology Master Fund Ltd | 13.39% | 15,726,349 | $243.44M | Insider |
| Deep Track Capital LP | 13.39% | 15,726,349 | $243.44M | Institution |
| Symphony Capital Partners LP | 7.69% | 9,031,431 | $139.81M | Insider |
| Vanguard Group Inc | 6.90% | 8,099,758 | $125.38M | Institution |
| James E. Flynn | 6.80% | 7,982,041 | $123.56M | Insider |
| State Street Corp | 5.35% | 6,285,477 | $97.30M | Institution |
| Millennium Management LLC | 3.86% | 4,528,415 | $70.10M | Institution |
| Chicago Capital LLC | 3.67% | 4,308,802 | $66.70M | Institution |